Because of reduced signaling of these regulators, tumor-residing CD8+ T-cells upregulate checkpoint molecules, such as PD-1, CTLA-4, LAG-3, and TIM-3, reflecting the exhausted state of these cells. The gene discussed is CD8A; the disease is neoplasm.